Other Key Findings Metabolic improvements: Participants saw reductions in A1C (for those with prediabetes or diabetes), fasting glucose, and triglycerides Liver fat reduction: Retatrutide reduced liver fat by up to 50%, which is why Eli Lilly added a NASH-specific trial to the Phase 3 program Side effects: Mostly gastrointestinal (nausea, diarrhea, constipation), similar to other GLP-1 drugs but manageable with slow titration Discontinuation rate: About 10% of participants stopped due to side effects, comparable to tirzepatide and semaglutide Study limitation: The Phase 2 trial was only 48 weeks long
The downside of Glutathione pills to stop drinking is they are not as effective in oral form
Two invoices followed: $845,205 on September 1, $216,330 on September 8
Rao often recommends the Lilly Direct program, which allows patients to purchase medications directly from the company at a discounted rate, along with coupon codes and patient assistance programs